Literature DB >> 23725498

Overview of age-related ocular conditions.

Esen K Akpek1, Roderick A Smith.   

Abstract

The United States is an aging society. The number of Americans 65 years or older is expected to more than double over the next 40 years, from 40.2 million in 2010 to 88.5 million in 2050, with aging baby boomers accounting for most of the increase. As the society ages, the prevalence of age-related diseases, including diseases of the eye, will continue to increase. By 2020, age-related macular degeneration, one of the leading causes of vision loss, is expected to affect 2.95 million individuals in the United States. Likewise, the prevalence of open-angle glaucoma, estimated at 2.2 million in 2000, is projected to increase by 50%, to 3.36 million by 2020. As the eye ages, it undergoes a number of physiologic changes that may increase susceptibility to disease. Environmental and genetic factors are also major contributors to the development of age-related ocular diseases. This article reviews the physiology of the aging eye and the epidemiology and pathophysiology of 4 major age-related ocular diseases: age-related macular degeneration, glaucoma, diabetic retinopathy, and dry eye.

Entities:  

Mesh:

Year:  2013        PMID: 23725498

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  14 in total

1.  Mathematical modelling of glob-driven tear film breakup.

Authors:  L Zhong; C F Ketelaar; R J Braun; C G Begley; P E King-Smith
Journal:  Math Med Biol       Date:  2019-03-14       Impact factor: 1.854

2.  Topical nutraceutical Optixcare EH ameliorates experimental ocular oxidative stress in rats.

Authors:  Peter F Kador; Changmei Guo; Hiroyoshi Kawada; James Randazzo; Karen Blessing
Journal:  J Ocul Pharmacol Ther       Date:  2014-09       Impact factor: 2.671

3.  A Programmable Optical Stimulator for the Drosophila Eye.

Authors:  Xinping Chen; Walter D Leon-Salas; Taylor Zigon; Donald F Ready; Vikki M Weake
Journal:  HardwareX       Date:  2017-07-10

4.  Simulation of a central scotoma using contact lenses with an opaque centre.

Authors:  Essam S Almutleb; Arthur Bradley; Jason Jedlicka; Shirin E Hassan
Journal:  Ophthalmic Physiol Opt       Date:  2018-01       Impact factor: 3.117

5.  Protein Microarrays for Ocular Diseases.

Authors:  Guillermo Solís-Fernández; Ana Montero-Calle; Miren Alonso-Navarro; Miguel Ángel Fernandez-Torres; Victoria Eugenia Lledó; María Garranzo-Asensio; Rodrigo Barderas; Ana Guzman-Aranguez
Journal:  Methods Mol Biol       Date:  2021

6.  Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats.

Authors:  Kaavya Gudapati; Anayesha Singh; Danielle Clarkson-Townsend; Stephen Q Phillips; Amber Douglass; Andrew J Feola; Rachael S Allen
Journal:  J Vis Exp       Date:  2020-10-23       Impact factor: 1.355

7.  Molecular Characterization of Notch1 Positive Progenitor Cells in the Developing Retina.

Authors:  Galina Dvoriantchikova; Isabel Perea-Martinez; Steve Pappas; Ariel Faye Barry; Dagmara Danek; Xenia Dvoriantchikova; Daniel Pelaez; Dmitry Ivanov
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 8.  Factors Affecting Cirrus-HD OCT Optic Disc Scan Quality: A Review with Case Examples.

Authors:  Joshua S Hardin; Giovanni Taibbi; Seth C Nelson; Diana Chao; Gianmarco Vizzeri
Journal:  J Ophthalmol       Date:  2015-08-13       Impact factor: 1.909

9.  Health risk appraisal in older people 6: factors associated with self-reported poor vision and uptake of eye tests in older people.

Authors:  Steve Iliffe; Kalpa Kharicha; Danielle Harari; Cameron Swift; Gerhard Gillmann; Andreas E Stuck
Journal:  BMC Fam Pract       Date:  2013-09-03       Impact factor: 2.497

10.  Comparison between flipped classroom and lecture-based classroom in ophthalmology clerkship.

Authors:  Fen Tang; Chuan Chen; Yi Zhu; Chengguo Zuo; Yimin Zhong; Nan Wang; Lijun Zhou; Yuxian Zou; Dan Liang
Journal:  Med Educ Online       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.